Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice. (Q51465818)
Jump to navigation
Jump to search
scientific article published in September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice. |
scientific article published in September 2007 |
Statements
Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice. (English)
1 reference
Rameshwar Jatwa
1 reference
Sunanda Panda
1 reference
Anand Kar
1 reference
1 September 2007
1 reference
101
1 reference
3
1 reference
177-180
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference